Faculty of 1000 evaluation for Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing.

James Crowe
  • October 2007, Faculty of 1000, Ltd.
  • DOI: 10.3410/f.1093763.548682

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication


The following have contributed to this page: Dr James E Crowe